Eton Pharmaceuticals (ETON) Set to Announce Quarterly Earnings on Thursday

Eton Pharmaceuticals (NASDAQ:ETON) is scheduled to be releasing its earnings data after the market closes on Thursday, May 9th. Analysts expect Eton Pharmaceuticals to post earnings of ($0.02) per share for the quarter. Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Eton Pharmaceuticals (NASDAQ:ETON) last released its quarterly earnings results on Thursday, March 14th. The company reported ($0.09) EPS for the quarter, missing the consensus estimate of ($0.04) by ($0.05). Eton Pharmaceuticals had a negative return on equity of 6.21% and a negative net margin of 2.96%. The business had revenue of $7.31 million during the quarter, compared to analyst estimates of $7.70 million.

Eton Pharmaceuticals Stock Up 5.1 %

Shares of NASDAQ ETON opened at $3.68 on Thursday. The business has a 50 day moving average price of $3.83 and a two-hundred day moving average price of $4.08. Eton Pharmaceuticals has a fifty-two week low of $2.42 and a fifty-two week high of $5.81. The firm has a market cap of $94.54 million, a PE ratio of -125.67 and a beta of 1.17.

About Eton Pharmaceuticals

Eton Pharmaceuticals, Inc, a specialty pharmaceutical company, focuses on developing, acquiring, and commercializing pharmaceutical products for rare diseases. The company offers ALKINDI SPRINKLE, a replacement therapy for adrenocortical insufficiency in children under 17 years of age; Carglumic Acid for the treatment of acute and chronic hyperammonemia due to N-acetylglutamate Synthase deficiency; Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of tyrosinemia type 1.